{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:11:50Z","timestamp":1767834710072,"version":"3.49.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.atherosclerosis.2005.10.007","type":"journal-article","created":{"date-parts":[[2005,11,29]],"date-time":"2005-11-29T12:41:32Z","timestamp":1133268092000},"page":"227-239","source":"Crossref","is-referenced-by-count":111,"title":["Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectives"],"prefix":"10.1016","volume":"185","author":[{"given":"Andrea J.","family":"Cussons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bronwyn G.A.","family":"Stuckey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald F.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Consensus Statement: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib2","series-title":"Polycystic ovary syndrome","first-page":"337","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadski","year":"1992"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib3","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1210\/jc.83.9.3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0895-4356(98)00010-9","article-title":"Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study","volume":"51","author":"Talbott","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jc.84.1.165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-2007-1009245","article-title":"Anthropometric variables and metabolism in polycystic ovarian disease","volume":"21","author":"Rebuffe-Scrive","year":"1989","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib7","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diabetes.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome","volume":"111","author":"Legro","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib9","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/humrep\/16.9.1995","article-title":"Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome","volume":"16","author":"Norman","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1210\/jcem-50-1-113","article-title":"Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease","volume":"50","author":"Burghen","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib11","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1210\/jc.83.6.2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system","volume":"83","author":"Nestler","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib12","doi-asserted-by":"crossref","first-page":"s61","DOI":"10.1016\/S0025-6196(19)30645-7","article-title":"Androgen effect on insulin action and glucose metabolism","volume":"75","author":"Rizza","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib13","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.CIR.103.10.1410","article-title":"Polycystic ovary syndrome is associated with endothelial dysfunction","volume":"103","author":"Paradisi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib14","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1210\/jc.85.5.1851","article-title":"Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome","volume":"85","author":"Mather","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib15","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/jc.2004-0751","article-title":"Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation","volume":"89","author":"Tarkun","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib16","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1161\/01.CIR.93.7.1331","article-title":"Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease","volume":"93","author":"Petrie","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1056-8727(01)00209-4","article-title":"Insulin resistance and vascular function","volume":"16","author":"Baron","year":"2002","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1210\/er.2001-0025","article-title":"Androgens and coronary artery disease","volume":"24","author":"Wu","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1210\/er.2003-0005","article-title":"Androgens and cardiovascular disease","volume":"24","author":"Liu","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib20","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/bmj.311.7014.1193","article-title":"Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women","volume":"311","author":"Barrett-Connor","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib21","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1210\/jc.84.6.2008","article-title":"Endogenous androgens and carotid intimal-medial thickness in women","volume":"84","author":"Bernini","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2265.1997.2601068.x","article-title":"Mortality and morbidity in transsexual subjects treated with cross-sex hormones","volume":"47","author":"van Kesteren","year":"1997","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib23","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/01.ATV.15.5.562","article-title":"Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness","volume":"15","author":"Adams","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib24","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1210\/jc.82.10.3389","article-title":"Altered composition of high density lipoproteins in women with the polycystic ovary syndrome","volume":"82","author":"Rajkhowa","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib25","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jc.86.6.2453","article-title":"Low grade chronic inflammation in women with polycystic ovarian syndrome","volume":"86","author":"Kelly","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib26","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1210\/jc.2003-031096","article-title":"Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease","volume":"89","author":"Boulman","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib27","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1530\/eje.0.1500525","article-title":"The polycystic ovary syndrome per se is not associated with increased chronic inflammation","volume":"150","author":"Mohlig","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib28","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/humrep\/deg353","article-title":"Serum adiponectin levels in women with polycystic ovary syndrome","volume":"18","author":"Panidis","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib29","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-2265.2004.02159.x","article-title":"Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome","volume":"61","author":"Spranger","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1046\/j.1365-2265.1996.00863.x","article-title":"Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome","volume":"45","author":"Sampson","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0015-0282(16)56575-3","article-title":"Hemostatic and metabolic variables in women with polycystic ovary syndrome","volume":"61","author":"Dahlgren","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib32","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1210\/jc.86.10.4666","article-title":"Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy","volume":"86","author":"Diamanti-Kandarakis","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000058367","article-title":"The plasma homocysteine levels are increased in polycystic ovary syndrome","volume":"53","author":"Loverro","year":"2002","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0009-9120(01)00245-4","article-title":"Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease","volume":"34","author":"Sabuncu","year":"2001","journal-title":"Clin Biochem"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib35","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.ATV.15.7.821","article-title":"Coronary heart disease risk factors in women with polycystic ovary syndrome","volume":"15","author":"Talbott","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib36","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2796.2003.01229.x","article-title":"Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults","volume":"254","author":"Dalton","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/01.ATV.10.4.497","article-title":"Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease","volume":"10","author":"Despres","year":"1990","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib38","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.288.16.2008","article-title":"Platelet activation in obese women: role of inflammation and oxidant stress","volume":"288","author":"Davi","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib39","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.2337\/diabetes.51.9.2734","article-title":"Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein","volume":"51","author":"Nishizawa","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib40","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1210\/jc.86.3.1175","article-title":"Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome","volume":"86","author":"Fogel","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1210\/jc.86.2.517","article-title":"Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance","volume":"86","author":"Vgontzas","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2265.1992.tb02295.x","article-title":"Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome","volume":"37","author":"Conway","year":"1992","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib43","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/00016349209006227","article-title":"Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women","volume":"71","author":"Dahlgren","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/oxfordjournals.humrep.a019028","article-title":"Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state?","volume":"11","author":"Holte","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib45","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)","volume":"285","author":"Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib46","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib47","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0026-0495(03)00104-5","article-title":"Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome","volume":"52","author":"Glueck","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib48","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF03345285","article-title":"Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome","volume":"27","author":"Faloia","year":"2004","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib49","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1210\/jc.2003-032237","article-title":"Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome","volume":"89","author":"Talbott","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib50","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3109\/09513599909167585","article-title":"Prevalence of a positive family history of type 2 diabetes in women with polycystic ovarian disease","volume":"13","author":"Fox","year":"1999","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib51","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2265.2002.01603.x","article-title":"Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?","volume":"57","author":"Wijeyaratne","year":"2002","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib52","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1001\/jama.292.13.1588","article-title":"Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality","volume":"292","author":"Daviglus","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib53","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2337\/diacare.28.9.2289","article-title":"The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes","volume":"28","author":"Kahn","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib54","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u2014a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib55","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","article-title":"Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study","volume":"52","author":"Wild","year":"2000","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib56","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1210\/jc.87.5.2013","article-title":"Menstrual cycle irregularity and risk for future cardiovascular disease","volume":"87","author":"Solomon","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000064682","article-title":"Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy","volume":"98","author":"Schannwell","year":"2002","journal-title":"Cardiology"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib58","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0735-1097(02)01896-X","article-title":"Prognostic significance of left ventricular diastolic dysfunction in essential hypertension","volume":"39","author":"Schillaci","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib59","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0735-1097(93)90850-Z","article-title":"Diastolic failure: pathophysiology and therapeutic implications","volume":"22","author":"Brutsaert","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib60","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/CS20030211","article-title":"Ventricular dysfunction in early diabetic heart disease: detection, mechanisms and significance","volume":"105","author":"Watts","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib61","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/humrep\/14.8.1949","article-title":"Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome","volume":"14","author":"Tiras","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib62","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1210\/jc.2003-032049","article-title":"The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study","volume":"89","author":"Orio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib63","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.2337\/diabetes.51.10.3020","article-title":"Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance","volume":"51","author":"Iozzo","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib64","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1097\/00004872-200212000-00002","article-title":"Carotid intima-media thickness, arterial stiffness and risk of cardiovascular disease: current evidence","volume":"20","author":"Bots","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib65","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/j.arrt.2004.02.008","article-title":"Arterial stiffness and function in end-stage renal disease","volume":"11","author":"London","year":"2004","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib66","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1210\/jc.87.2.742","article-title":"Altered vascular function in young women with polycystic ovary syndrome","volume":"87","author":"Kelly","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib67","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1042\/CS19990319","article-title":"Internal carotid artery haemodynamics in women with polycystic ovaries","volume":"98","author":"Lakhani","year":"2000","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib68","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1210\/jc.2004-1487","article-title":"Vascular dysfunction and metabolic parameters in polycystic ovary syndrome","volume":"90","author":"Meyer","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib69","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/qjmed\/hch089","article-title":"Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the \u2018recoupling hypothesis\u2019","volume":"97","author":"Chew","year":"2004","journal-title":"Qjm"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib70","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0140-6736(92)93147-F","article-title":"Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis","volume":"340","author":"Celermajer","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib71","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1210\/jc.2003-031867","article-title":"Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome","volume":"89","author":"Orio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib72","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1210\/jc.2005-0151","article-title":"Predictors of endothelial dysfunction in young women with polycystic ovary syndrome","volume":"90","author":"Kravariti","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib73","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1530\/eje.1.01910","article-title":"Metformin administration improves endothelial function in women with polycystic ovary syndrome","volume":"152","author":"Diamanti-Kandarakis","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib74","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1521-690X(03)00033-2","article-title":"Insulin resistance and endothelial dysfunction","volume":"17","author":"Yki-Jarvinen","year":"2003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib75","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00125-002-0800-2","article-title":"Vascular function, insulin resistance and fatty acids","volume":"45","author":"Steinberg","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib76","doi-asserted-by":"crossref","first-page":"H981","DOI":"10.1152\/ajpheart.2001.281.3.H981","article-title":"Vascular endothelial dysfunction: does tetrahydrobiopterin play a role?","volume":"281","author":"Katusic","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib77","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/01.RES.88.2.145","article-title":"Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia","volume":"88","author":"Mullen","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib78","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1440-1681.1998.tb02269.x","article-title":"Non-invasive measurement of endothelial function","volume":"25","author":"Playford","year":"1998","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib79","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1210\/jc.2002-020386","article-title":"Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome","volume":"88","author":"Paradisi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib80","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/01.ATV.0000044461.01844.C9","article-title":"Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells","volume":"23","author":"Calnek","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib81","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/jcp.2003.015271","article-title":"Cardiovascular risk in women with polycystic ovarian syndrome (PCOS)","volume":"58","author":"Bickerton","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib82","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.thromres.2004.11.026","article-title":"Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome","volume":"116","author":"Carmassi","year":"2005","journal-title":"Thromb Res"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib83","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0002-9378(96)70665-8","article-title":"Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study","volume":"174","author":"Guzick","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib84","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.20.11.2414","article-title":"Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women","volume":"20","author":"Talbott","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib85","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1093\/humrep\/dei100","article-title":"Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome","volume":"20","author":"Vural","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib86","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1210\/jc.2004-2363","article-title":"Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome","volume":"90","author":"Vryonidou","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib87","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2003-030334","article-title":"Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome","volume":"88","author":"Christian","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib88","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7326\/0003-4819-126-1-199701010-00005","article-title":"Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization","volume":"126","author":"Birdsall","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib89","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","article-title":"Diabetes and atherosclerosis: epidemiology, pathophysiology, and management","volume":"287","author":"Beckman","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib90","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jacc.2004.02.001","article-title":"Evidence-based guidelines for cardiovascular disease prevention in women","volume":"43","author":"Mosca","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib91","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome: systematic review and meta-analysis","volume":"327","author":"Lord","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib92","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/humrep\/deg264","article-title":"Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome","volume":"18","author":"Romualdi","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.atherosclerosis.2005.10.007_bib93","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/humrep\/16.10.2066","article-title":"Clinical, endocrine and metabolic effects of acarbose, an alpha-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance","volume":"16","author":"Ciotta","year":"2001","journal-title":"Hum Reprod"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191500500660X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191500500660X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T06:59:39Z","timestamp":1586588379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191500500660X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S002191500500660X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2005.10.007","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}